Related Experiment Videos
Perforin-mediated target cell lysis by cytolytic T lymphocytes
Annual Review of Immunology
|January 1, 1990
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Loco-regional complications of pharyngitis: the example of Lemierre's syndrome].
Revue medicale suisse·2015
Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.
Brain, behavior, and immunity·2015
A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants.
Blood cancer journal·2012
ER stress activates the NLRP3 inflammasome via an UPR-independent pathway.
Cell death & disease·2012
The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade.
Cell death and differentiation·2011
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome.
Cell death & disease·2011
The Neuroimmune Circuitry of Peripheral Sensory Neuron Subtypes in Chronic Pain.
Annual review of immunology·2026
The Spectrum of Fibroblast Immune Biology.
Annual review of immunology·2026
The Molecular Logic of Immunoglobulin Heavy Chain Class Switch Recombination.
Annual review of immunology·2026
Decoding Human T Cell Immunity with Artificial Intelligence and Single-Cell Genomics.
Annual review of immunology·2026
Immune Niches in Cancer.
Annual review of immunology·2026
T Cell Receptor Signaling and Immune Tolerance: From Autoimmunity to Cancer Immunity.
Annual review of immunology·2026
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026